• letlifehappen's Avatar

    letlifehappen posted a blog post

    From: PR Newswire – There have been no newly approved therapies over the last 25 years for “high risk” locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) patients –  The FDA decision was based on the compelling magnitude of the clinically phase II findings in combination with chemo-radiotherapy presented in September 2019 at the ESMO congress (European Society ...
    The post FDA Grants Breakthrough Therapy Designation for Debiopharm’s Novel Chemo-Radio Sensitizer Debio 1143 for Front-line Treatment of Head & Neck Cancer appeared first on Let Life Happen.